生物活性 | |||
---|---|---|---|
描述 | BV02 is a potent 14-3-3 protein-protein interaction inhibitor. BV02 is cytotoxic to imatinib mesylate-sensitive wild-type Bcr-Abl and imatinib mesylate-resistant T315I mutant haematopoietic cells. BV02 has potential for the study of chronic granulocytic leukaemia [1][2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.65mL 0.53mL 0.27mL |
13.25mL 2.65mL 1.33mL |
26.50mL 5.30mL 2.65mL |
参考文献 |
---|